Quotient Sciences Acquires Arcinova

Read the press release here

Business Development

Gail brings over 20 years of pharmaceutical sales and life sciences business development experience to Arcinova. She previously served as Senior Director of Business Development for Covance Early Clinical services, and PAREXEL Phase II-IV Clinical services. Most recently, Gail was Assistant Director, Strategic Business Development at the Duke Clinical Research Institute. Her career includes appointments at Merck, Pfizer, PPD and Charles River where she worked in various business development roles and managing key accounts.  

She holds a BS in Psychology from North Carolina State University and a BA in Criminal Justice Administration from the University of North Carolina at Chapel Hill.

Gail is based in Raleigh, North Carolina and oversees business development activities for Arcinova in the US.  

“I am honoured and privileged to work alongside world-renowned researchers and visionaries in the pharmaceutical industry. One of the most rewarding aspects of my job, is seeing the successful outcomes of their collaborations. Being a part of that team is extremely satisfying.”  

Masha brings over 20 years of Business Development and R&D experience to Arcinova, having previously served as business development executive for Catalent Pharma Solutions, DSM Pharmaceuticals and Cirrus Pharmaceuticals. 

As well as extensive R&D experience at Wyeth, Syngenta and Purdue University, Masha has played a key role in establishing a significant client base for two start-up companies. 

Masha holds a MS Degree in Molecular Biology from Moscow State Pedagogical University, and is fluent in Russian.

Masha is based in Raleigh, North Carolina and oversees business development activities for emerging pharma in the US.  

"Throughout my career I have always been passionate about science and building effective relationships by understanding the clients’ needs. The biggest reward is to see successful outcomes of collaborations that can help develop new medicines for patients. Being a part of an exceptionally talented team of life science professionals is very satisfying.”  

Since joining Arcinova in 2018, Louise has continuously contributed to Arcinova’s sales efforts, initially within the Client Service team and, more recently, in 2020, joining the Business Development team.  During this time, she has gained valuable skills and experience, which helped her progress into her current customer facing role. As a Business Development Associate, Europe, Louise fully supports the growth of our European sales, with a focus on UK clients.

Louise also has previous experience working as a laboratory analyst in a large pharmaceutical CMO, Piramal Healthcare,

“I enjoy the diversity of each client’s project; how each molecule requires a different customised solution to unlock its true potential. I find this extremely exciting”

Nathalie started her career as a synthetic and process chemist in drug discovery and development.

For the last 10 years, she has held various management positions in both tactical and strategic marketing and, more recently, in sales and business development, promoting services and products addressing the needs of the pharmaceutical and biotech markets in Europe, the Middle East and Africa.

Previous employers include Sigma-Aldrich, Excelsyn, AstraZeneca and Pharmorphix (now owned by Johnson Matthey).

Nathalie holds BSc and MSc degrees in Chemistry from the University of Strasbourg (France) and a PhD in Organic Chemistry from the University of York, and is fluent in French and German.

“I thrive in offering a consultative approach to sales and business development. Understanding our clients’ needs is key to ensure we offer the best solution to their specific requirements. I get the greatest satisfaction in the knowledge that we have successfully fulfilled those needs”

Originally a molecular biologist, Mark has spent 18 years in the drug discovery and development industry in both project management and commercial roles. Previous relevant positions include CEO at AIM-listed Physiomics plc, VP Business Development at Excelsyn and Director of Commercial Operations at BioFocus. 

Mark holds a degree in Genetics from the University of Nottingham, a PhD in Molecular Biology from the University of Newcastle and an MBA from Imperial College London.

"Throughout my career I have always been passionate about providing drug discovery and development services to customers. I gain a great deal of satisfaction from collaborating with biotechnology and pharmaceutical companies and being part of a team who deliver solutions that are often of critical importance to our partners."

After graduating in 2012, Faye has gained experience in Marketing and Events Management. Her previous roles have all been client centric, focussing on business development and sales.

Faye is a qualified project manager and holds an honours degree in Business with Marketing and an MSc in Project Management, both of which are from Northumbria University.

"We are very focussed on responding to customer enquiries, listening to their requirements and delivering on those in order to provide the best possible service. After all, the better we understand our clients requirements, the more efficient and effective we will be."